These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9660375)

  • 41. Serotonergic function in cocaine addicts: prolactin responses to sequential D,L-fenfluramine challenges.
    Buydens-Branchey L; Branchey M; Hudson J; Rothman M; Fergeson P; McKernin C
    Biol Psychiatry; 1999 May; 45(10):1300-6. PubMed ID: 10349036
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hormonal responses to dl-fenfluramine challenge are not blunted in seasonal affective disorder.
    Yatham LN; Michalon M
    Psychoneuroendocrinology; 1995; 20(4):433-8. PubMed ID: 8532826
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prolactin and cortisol responses to fenfluramine challenge in mania.
    Yatham LN
    Biol Psychiatry; 1996 Feb; 39(4):285-8. PubMed ID: 8645775
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cholesterol and serotonin indices in depressed and suicidal patients.
    Sarchiapone M; Camardese G; Roy A; Della Casa S; Satta MA; Gonzalez B; Berman J; De Risio S
    J Affect Disord; 2001 Feb; 62(3):217-9. PubMed ID: 11223109
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stress hormone dysregulation at rest and after serotonergic stimulation among alcohol-dependent men with extended abstinence and controls.
    Anthenelli RM; Maxwell RA; Geracioti TD; Hauger R
    Alcohol Clin Exp Res; 2001 May; 25(5):692-703. PubMed ID: 11411461
    [TBL] [Abstract][Full Text] [Related]  

  • 46. d-fenfluramine-induced prolactin responses in mania: evidence for serotonergic subsensitivity.
    Thakore JH; O'Keane V; Dinan TG
    Am J Psychiatry; 1996 Nov; 153(11):1460-3. PubMed ID: 8890681
    [TBL] [Abstract][Full Text] [Related]  

  • 47. D-fenfluramine-evoked serotonergic responses in olanzapine-treated schizophrenic patients.
    Jones H; Curtis VA; Wright P; Pilowsky LS; Lucey JV
    Psychiatry Res; 2002 Dec; 113(1-2):41-7. PubMed ID: 12467944
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serotonergic function and negative and depressive symptomatology in schizophrenia and major depression.
    Abel KM; O'Keane V; Murray RM; Cleare AJ
    Psychoneuroendocrinology; 1997 Oct; 22(7):539-48. PubMed ID: 9373887
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prolactin response to fenfluramine administration in patients with unipolar and bipolar depression and healthy controls.
    Sher L; Oquendo MA; Li S; Ellis S; Brodsky BS; Malone KM; Cooper TB; Mann JJ
    Psychoneuroendocrinology; 2003 May; 28(4):559-73. PubMed ID: 12689612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum cholesterol and serotonergic function in major depressive disorder.
    Papakostas GI; Petersen T; Mischoulon D; Hughes ME; Alpert JE; Nierenberg AA; Rosenbaum JF; Fava M
    Psychiatry Res; 2003 May; 118(2):137-45. PubMed ID: 12798978
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hormonal responses to fenfluramine in depressed and control subjects.
    Mitchell P; Smythe G
    J Affect Disord; 1990 May; 19(1):43-51. PubMed ID: 2140846
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prolactin response to d-fenfluramine in postmenopausal women on and off ERT: comparison with young women.
    van Amelsvoort TA; Abel KM; Robertson DM; Daly E; Critchley H; Whitehead M; Murphy DG
    Psychoneuroendocrinology; 2001 Jul; 26(5):493-502. PubMed ID: 11337133
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma prolactin response to d-fenfluramine in obsessive-compulsive patients before and after fluvoxamine treatment.
    Monteleone P; Catapano F; Bortolotti F; Maj M
    Biol Psychiatry; 1997 Aug; 42(3):175-80. PubMed ID: 9232209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects.
    Cleare AJ; Murray RM; O'Keane V
    Neuropsychopharmacology; 1996 May; 14(5):349-54. PubMed ID: 8703303
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hormone responses to fenfluramine and placebo challenge in endogenous depression.
    Lichtenberg P; Shapira B; Gillon D; Kindler S; Cooper TB; Newman ME; Lerer B
    Psychiatry Res; 1992 Aug; 43(2):137-46. PubMed ID: 1410069
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of fenfluramine challenge on cocaine craving in addicted male users.
    Buydens-Branchey L; Branchey M; Hudson J; Rothman M; Fergeson P; McKernin C
    Am J Addict; 1998; 7(2):142-55. PubMed ID: 9598218
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Future suicide attempt and responses to serotonergic challenge.
    Keilp JG; Oquendo MA; Stanley BH; Burke AK; Cooper TB; Malone KM; Mann JJ
    Neuropsychopharmacology; 2010 Apr; 35(5):1063-72. PubMed ID: 18354392
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impulsivity, gender, and response to fenfluramine challenge in borderline personality disorder.
    Soloff PH; Kelly TM; Strotmeyer SJ; Malone KM; Mann JJ
    Psychiatry Res; 2003 Jul; 119(1-2):11-24. PubMed ID: 12860356
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prolactin response to D-fenfluramine in outpatients with major depression.
    Kavoussi RJ; Kramer J; Hauger RL; Coccaro EF
    Psychiatry Res; 1998 Jul; 79(3):199-205. PubMed ID: 9704866
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of valine on 5-HT-mediated prolactin release in healthy volunteers, and on mood in remitted depressed patients.
    Williamson DJ; McTavish SF; Park SB; Cowen PJ
    Br J Psychiatry; 1995 Aug; 167(2):238-42. PubMed ID: 7582676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.